A Pilot Study of Anti-CTLA4 Antibody Ipilimumab in Patients with Synovial Sarcoma

Background. Patients with recurrent synovial sarcomas have few options for systemic therapy. Since they express large amounts of endogenous CT (cancer testis) antigens such as NY-ESO-1, we investigated the clinical activity of single agent anti-CTLA4 antibody ipilimumab in patients with advanced or...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Maki, Robert G., Jungbluth, Achim A., Gnjatic, Sacha, Schwartz, Gary K., D'Adamo, David R., Keohan, Mary Louise, Wagner, Michael J., Scheu, Kelly, Chiu, Rita, Ritter, Erika, Kachel, Jennifer, Lowy, Israel, Old, Lloyd J., Ritter, Gerd
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2013
Assuntos:
Clinical Study
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3608267/
https://ncbi.nlm.nih.gov/pubmed/23554566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/168145
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares